Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate [PDF]
The safety of long-acting β-agonists added to inhaled corticosteroids for the treatment of persistent asthma has been controversial.We sought to determine whether administering formoterol in combination with mometasone furoate increases the risk of serious asthma outcomes (SAOs) compared with mometasone furoate alone.
Ioana Agache +2 more
exaly +3 more sources
Simultaneous determination of mometasone furoate and calcipotriol in a binary mixture by validated HPLC and chemometric-assisted UV spectrophotometric methods and identification of degradation products by LC-MS. [PDF]
Objective(s): A new binary mixture containing mometasone furoate (MF) and calcipotriol (CP) is suggested to manage psoriasis; since the combined stability profile of these drugs is poorly understood.
Jahani M +6 more
europepmc +2 more sources
Clinical study of the effect of mometasone furoate nasal spray treatment on hearing and in secretory otitis media in children. [PDF]
Highlights • The total effective rate of treatment in the observation group was higher than that in the control group.• The middle ear resonance frequency of the children in the observation group was higher than that of the control group at weeks 4, 8 ...
Yu X, Xu L, Xie Y, Huang M.
europepmc +2 more sources
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial. [PDF]
The aim of this study was to evaluate the usage of mometasone furoate nasal spray in the recovery of patients with severe microsmia or anosmia induced by COVID-19.
Kasiri H +4 more
europepmc +2 more sources
Background Otitis media with effusion (OME) is one of the commonest causes of hearing loss in children. Oral and nasal topical steroids alone or combined with antibiotics lead to its quicker resolution.
Mohamed Rifaat Ahmed +1 more
doaj +2 more sources
Background: Among various therapeutic options for treating vitiligo, the search for an effective agent to minimize disease progression and achieve repigmentation continues.
Abhishek Kumar +3 more
doaj +2 more sources
Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs. [PDF]
Today, the approval for a generic topical product includes the presentation of therapeutic equivalence to the originator based on clinical trials. To facilitate this procedure, in 2018 the European Medicines Agency (EMA) published a draft guideline on ...
Eichner A +3 more
europepmc +2 more sources
Advances in the management of allergic rhinitis: clinical relevance of the mometasone furoate–olopatadine association and the challenge of patient self-diagnosis and self-treatment [PDF]
Allergic rhinitis is a highly prevalent inflammatory disease that significantly impairs sleep, daily functioning and quality of life, with symptoms increasingly amplified by environmental changes such as prolonged pollen seasons and urban pollution ...
Maria D’Amato, Gennaro D’Amato
doaj +2 more sources
Mometasone furoate is not superior to saline for chronic rhinitis in the elderly [PDF]
Introduction: Prevalence of diseases associated with ageing is rising; among these are the rhinologic problems. Chronic rhinitis appears as one of the most common worrisome nasal disorders in this age group. At the same time, the allergic form diminishes
Victor Carvalho +3 more
doaj +2 more sources
Evaluation of rheological and mucoadhesive properties of selected nasal spray preparations with mometasone furoate [PDF]
Intranasal preparations with mometasone furoate are recognised to be highly efficient and safe in both adults and children. Commercially available nasal sprays are characterised by thixotropic and mucoadhesive properties – factors ensuring effortless ...
Emilia Szymańska, Katarzyna Winnicka
doaj +2 more sources

